AI-Mind has been granted access to EBRAIN’s implementation support among thirteen other innovative projects from Europe, United States, and Canada. Together with a dedicated expert from Human Brain Project, AI-Mind will develop and implement tailored infrastructure features to enhance brain modeling and simulation platform. AI-Mind develops a new biomarker in dementia and a new class 2b medical device to effectively screen and predict the risk of dementia in the MCI affected European population. With the merge of our AI-MIND data into the HBP infrastructure provided by the EBRAIN, the AI-Mind project will be able to better model the algorithm, test, and finally apply AI-based diagnostics in clinical settings. As an HBP Partnering Project, we will have the opportunity to develop further collaborations and make a huge impact on health and technological progress.